Siegel Jolie 4
4 · C4 Therapeutics, Inc. · Filed Aug 31, 2023
Insider Transaction Report
Form 4
Siegel Jolie
Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2023-08-30$2.93/sh−661$1,937→ 26,686 total - Exercise/Conversion
Common Stock
2023-08-30+2,250→ 27,347 total - Exercise/Conversion
Performance Restricted Stock Units
2023-08-30−2,250→ 16,500 totalExp: 2025-02-28→ Common Stock (2,250 underlying)
Footnotes (2)
- [F1]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person.